Peptidic, Peptidomimetic, and HTS-Derived BACE Inhibitors

BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease

Volumn , Issue , 2010, Pages 59-105

  Beck, James P ^a   Mergott, Dustin J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Oklahoma Medical Research Foundation (OMRF) multiple collaborators; Peptidic, peptidomimetic and HTS derived BACE inhibitors; Schering Plough Corporation and HEA BACE 1 inhibitors

Indexed keywords

EID: 77955432112     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470594087.ch4     Document Type: Chapter

References (196)

1. Silvestri, R. 2009 . Boom in the development of non-peptidic β-secretase (BACE1) inhibitors for the treatment of Alzheimer ' s disease . Med Res Rev 29 : 295-338 .
2. Stachel, S.J. 2009 . Progress toward the development of a viable BACE-1 inhibitor . Drug Dev Res 70 : 101-110 .
3. Tomita, T. 2009 . Secretase inhibitors and modulators for Alzheimer ' s disease treatment . Expert Rev Neurother 9 : 661-679.
4. Ghosh, A.K., Kumaragurubaran, N., Hong, L., Koelsh, G., and Tang, J. 2008 . Memapsin 2 (beta-secretase) inhibitors: drug development . Curr Azlheimer Res 5 : 121-131.
5. Ghosh, A.K., Gemma, S., and Tang, J. 2008 . β-Secretase as a therapeutic target for Alzheimer ' s disease . Neurotherapeutics 5 : 399-408.
6. Durham, T.B. and Shepherd, T.A. 2006 . Progress toward the discovery and development of efficacious BACE inhibitors . Curr Opin Drug Discov Devel 9 : 776-791.
7. John, V. 2006 . Human β-secretase (BACE) and BACE inihibitors: progress report . Curr Top Med Chem 6 : 569-578.
8. Ziora, Z., Kimura, T., and Kiso, Y. 2006 . Small-sized BACE1 inhibitors . Drugs of the Future 31 : 53-63.
9. John . V., Beck, J.P., Bienkowski, M.J., Sinha, S., and Heinrikson, R.L. 2003 . Human β-secretase (BACE) and BACE inhibitors . J Med Chem 46 : 4625-4630 .
10. Tung, J.S., Davis, D.L., Anderson, J.P., Walker, D.E., Mamo, S., Jewett, N., Hom, R.K., Sinha, S., Thorsett, E.D., and John, V. 2002 . Design of substrate-based inhibitors of human β-secretase . J Med Chem 45 : 259-262 .
11. Hom, R.K., Fang, L.Y., Mamo, S., Tung, J.S., Guinn, A.C., Walker, D.E., Davis, D.L., Gailunas, A.F., Thorsett, E.D., Sinha, S., Knopps, J.E., Jewett, N.E., Anderson, J.P., and John, V. 2003 . Design and synthesis of statine-based cell-permeable peptidomimetic inhibitors of human β-secretase . J Med Chem 46 : 1799-1802 .
12. John, V., Tung, J., Fang, L., and Mamo, S.S. 2000 . Preparation of statine-derived tetrapeptides as inhibitors of β-secretase. PCT Int Appl WO2000077030.
13. Schostarez, H.J. and Chrusciel, R.A. 2003 . Preparation of statine derivatives for the treatment of Alzheimer ' s disease. PCT Int Appl WO2003006021 .
14. Kaldor, S.W., Dressman, B.A., Hammond, M., Appelt, K., Burgess, J.A., Lubbehusen, P.P., Muesing, M.A., Hatch, S., Wiskerchen, M.A., and Baxter, A.J. 1995 . Isophthalic acid derivatives: amino acid surrogates for the inhibition of HIV-1 protease . Bioorg Med Chem Lett 5 : 721-726 .
15. Hom, R.K., Gailunas, A.F., Mamo, S., Fang, L.Y., Tung, J.S., Walker, D.E., Davis, D., Thorsett, E.D., Jewett, N.E., and John, V. 1995 . Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human β-secretase . J Med Chem 47 : 158-164 .
16. Gailunas, A., Tucker, J.A., and John, V. 2003 . Preparation of phenethylamines for the treatment of Alzheimer ' s disease. PCT Int Appl WO2003027068.
17. John, V., Hom, R., and Tucker, J. 2003 . Preparation of β-hydroxyamine derivatives for the treatment of Alzheimer ' s disease. PCT Int Appl WO2003002122.
18. Maillard, M. and Tucker, J.A. 2002 . Substituted aminoalcohols useful in treatment of Alzheimer ' s disease. PCT Int Appl WO2002100820.
19. Hom, R., Mamo, S., Tung, J., Gailunas, A., John, V., and Fang, L. 2001 . Preparation of hydroxyethylenes with peptide subunits for pharmaceutical use in the treatment of Alzheimer ' s disease. PCT Int Appl WO2001070672 .
20. Beck, J.P., Gailunas, A., Hom, R., Jagodzinska, B., John, V., and Maillaird, M. 2002 . Preparation of disubstituted amines for treating Alzheimer ' s disease. PCT Int Appl WO2002002520.
21. Maillaird, M., Hom, R., Gailunas, A., Jagodzinska, B., Fang, L.Y., John, V., Freskos, J.N., Pulley, S.R., Beck, J.P., and Tenbrink, R.E. 2002 . Preparation of substituted amines to treat Alzheimer ' s disease. PCT Int Appl WO2002002512.
22. Fang, L.Y., Hom, R., John, V., and Maillaird, M. 2002 . Preparation of substituted amines for treating Alzheimer ' s disease. PCT Int Appl WO2002002505 .
23. Maillard, M.C., Hom, R.K., Benson, T.E., Moon, J.B., Shumeye, M., Bienkowski, M., Tomasselli, A.G., Woods, D.D., Prince, D.B., Paddock, D.J., Emmons, T.L., Tucker, J.A., Dappen, M.S., Brogley, L., Thorsett, E.D., Jewett, N., Sinha, S., and John, V. 2007 . Design, synthesis, and crystal structure of hydroxyethyl secondary amine-based peptidomimetic inhibitors of human β-secretase . J Med Chem 50 : 776-781 .
24. Kortum, S.W., Benson, T.E., Bienkowski, M.J., Emmons, T.L., Prince, D.B., Paddock, D.J., Tomasselli, A.G., Moon, J.B., LaBorde, A., and Tenbrink, R.E. 2007 . Potent and selective isophthalamide S2 hydroxyethylamine inhibitors of BACE1 . Bioorg Med Chem Lett 17 : 3378-3383 .
25. Chirapu, S.R., Pachaiyappan, B., Nural, H.F., Cheng, X., Yuan, H., Lankin, D.C., Abdul-Hay, S.O., Thatcher, G.R.J., Shen, Y., Kozikowski, A.P., and Petukhov, P.A. 2009 . Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors . Bioorg Med Chem Lett 19 : 264-274 .
26. Freskos, J.N., Fobian, Y.M., Benson, T.E., Bienkowski, M.J., Brown, D.L., Emmons, T.L., Heintz, R., LaBorde, A., McDonald, J.J., Mischke, B.V., Molyneaux, J.M., Moon, J.B., Mullins, P.B., Prince, D.B., Pakkock, D.J., Tomasselli, A.G., and Winterrowd, G. 2007 . Design of potent inhibitors of human β-secretase. Part 1 . Bioorg Med Chem Lett 17 : 73-77 .
27. Freskos, J.N., Fobian, Y.M., Benson, T.E., Moon, J.B., Bienkowski, M.J., Brown, D.L., Emmons, T.L., Heintz, R., LaBorde, A., McDonald, J.J., Mischke, B.V., Molyneaux, J.M., Mullins, P.B., Prince, D.B., Paddock, D.J., Tomasselli, A.G., and Winterrowd, G. 2007 . Design of potent inhibitors of human β-secretase. Part 2 . Bioorg Med Chem Lett 17 : 78-81 .
28. Freskos, J., Aquino, J., Brown, D.L., Fang, L., Fobian, Y.M., Gailunas, A., Guinn, A., Varghese, J., Romero, A.G., Tucker, J., Tung, J., and Walker, D. Preparation of peptide-related hydroxyalkylamines for pharmaceutical use in the treatment of Alzheimer ' s disease. 2002 . PCT Int Appl WO2002098849 .
29. Pulley, S.R., Beck, J.P., and Tenbrink, R.E. 2002 . Macrocycles useful in the treatment of Alzheimer ' s disease. PCT Int Appl WO2002100856.
30. Pulley, S.R., Beck, J.P., Tenbrink, R.E., and Jacobs, J.S. 2002 . Preparation of macrocycles useful in the treatment of Alzheimer ' s disease. PCT Int Appl WO2002100399 .
31. Varghese, J., Jagodzinska, B., Maillard, M., Beck, J.P., Tenbrink, R.E., and Getman, D. 2003 . Preparation of substituted amines prodrugs useful in treating Alzheimer ' s disease. PCT Int Appl WO2003072535 .
32. Fobian, Y.M., Freskos, J.N., and Jagodzinska, B.A. 2004 . Preparation of 1,3-diamino-2-hydroxypropane derivatives as beta-secretase enzyme inhibitors. PCT Int Appl WO2004022523 .
33. Hurley, T.R., Colson, C.E., Hicks, G., and Ryan, M.J. 1993 . Orally active water-soluble N, O-acyl transfer products of a β, γ-bishydroxyl amide containing renin inhibitor . J Med Chem 36 : 1496-1498 .
34. Hamada, Y., Ohtake, J., Sohma, Y., Kimura, T., Hayashi, Y., and Kiso, Y. 2002 . New water-soluble prodrugs of HIV protease inhibitors based on O -< N intramolecular acyl migration . Bioorg Med Chem Lett 10 : 4155-4167 .
35. John, V., Maillard, M., Jagodzinska, B., Beck, J.P., Gailunas, A., Fang, L., Sealy, J., Tenbrink, R., Freskos, J., Mickelson, J., Samala, L., and Hom, R. 2003 . Preparation of N,N'-substituted-1,3-diamino-2-hydroxypropanes for treating Alzheimer ' s disease. PCT Int Appl WO2003040096 .
36. Gailunas, A., Hom, R., John, V., Maillard, M., Chrusciel, R.A., Fisher, J., Jacobs, J., Freskos, J.N., Brown, D.L., and Fobian, Y.M. 2003 . Preparation of N-(3-amino-2-hydroxy-propyl) substituted alkanamides as inhibitors of the beta secretase enzyme for treating Alzheimer ' s disease. PCT Int Appl WO2003006423 .
37. Pully, S.R. and Tucker, J.A. 2004 . Preparation of peptide-related substituted ureas and carbamates for the treatment of Alzheimer ' s disease. PCT Int Appl WO2004050609 .
38. Maillard, M.C., Baldwin, E.T., Beck, J.P., Hughes, R., John, V., Pulley, S.R., and Tenbrink, R. 2004 . Preparation of ring-containing N-acetyl 2-hydroxy-1,3-diaminoalkanes as β-secretase inhibitors for treating Alzheimer ' s disease and other diseases characterized by deposition of A β-peptide. PCT Int Appl WO2004024081 .
39. Bembenek, S.D., Tounge, B.A., and Reynolds, C.H. 2009 . Ligand efficiency and fragment-based drug discovery . Drug Discov Today 14 : 278-283.
40. Reynolds, C.H., Tounge, B.A., and Bembenek, S.D. 2008 . Ligand binding efficiency: trends, physical basis and implications . J Med Chem 51 : 2432-2438 .
41. John, V., Hom, R., Sealy, J., Tucker, J. 2006 . Methods of treatment of amyloidosis using bi-aryl aspartyl protease inhibitors. US Pat Appl Publ US2006014737 .
42. John, V., Maillard, M., Fang, L., Tucker, J., Brogley, L., Aquino, J., Bowers, S., Probst, G., and Tung, J. 2005 . Preparation of bicyclic compounds as aspartyl protease and β-secretase inhibitors for treating conditions associated with amyloidosis such as Alzheimer ' s disease. PCT Int Appl WO2005087714 .
43. John, V., Hom, R., Sealy, J., Aquino, J., Probst, G., Tung, J., and Fang, L. 2005 . Preparation of N-(3-amino-2-hydroxypropyl)acetamides as aspartyl protease and beta secretase inhibitors for treating conditions associated with amyloidosis such as Alzheimer ' s disease. PCT Int Appl WO2005070407 .
44. Neitz, R.J., Tisdale, E., Jagodzinska, B., Truong, A., and Tung, J.S. 2007 . Preparation of cyclopropyl fluorophenyl aminohydroxybutylamides as aspartyl protease inhibitors for treatment of amyloidosis. PCT Int Appl WO2007047305 .
45. Hom, R., Toth, G., Probst, G., Bowers, S., Truong, A., and Tung, J.S. 2007 . Preparation of aryl cyclopropyl (heterocyclyl) aminohydroxybutylamides as aspartyl protease inhibitors for treatment of amyloidosis. PCT Int Appl WO2007047306 .
46. Hom, R., Fang, L., and John, V. 2006 . Preparation of ethanol cyclic amine selective β-secretase inhibitors for treatment of amyloidosis. PCT Int Appl WO2006026533.
47. Hom, R., Fang, L., and John, V. 2006 . Methods of treatment of amyloidosis using substituted ethanolcyclicamine aspartyl protease inhibitors. PCT Int Appl WO2006026532.
48. Sealy, J., Hom, R., John, V., Probst, G., and Tung, J.S. 2006 . Preparation of oxime-containing N-(3-amino-1-arylmethyl-2-hydroxypropyl) carboxamide and related selective β-secretase inhibitors for treating amyloidosis. PCT Int Appl WO2006010094.
49. John, V., Maillard, M., Jagodzinska, B., Aquino, J., Probst, G., and Tung, J.S. 2006 . Preparation of oxime, hydrazone and other derivative substituted hydroxyethylamine selective β-secretase inhibitors for treating amyloidosis. PCT Int Appl WO2006010095.
50. Hom, R., Tucker J., John V., and Shah N. 2005 . Preparation of 2-amino-and 2-thio-substituted 1,3-diaminopropanes as β-secretase inhibitors for treating Alzheimer ' s disease and other diseases characterized by deposition of A β-peptide. PCT Int Appl WO2005095326.
51. John, V., Maillard, M., Tucker, J., Aquino, J., Jagodzinska, B., Brogley, L., Tung, J., Bowers, S., Dressen, D., Probst, G., and Shah, N. 2005 . Preparation of hydroxyethylamines as aspartyl protease inhibitors for treatment of amyloidosis. PCT Int Appl WO2005087751 .
52. Tenbrink, R., Maillard, M., and Warpehoski, M. 2003 . Preparation of substituted hydroxyethylamines as β-secretase inhibitors. PCT Int Appl WO2003050073 .
53. Aquino, J.R., John, V., Tucker, J.A., Hom, R., Pulley, S., and Tenbrink, R. 2004 . Preparation of phenacyl-substituted 2-hydroxy-3-diaminoalkanes as inhibitors of β-secretase. PCT Int Appl WO2004094413.
54. Aquino, J., John, V., Tucker, J.A., Hom, R., Pulley, S., Tenbrink, R. 2004 . Preparation of 2-hydroxy-3-aminoalkylbenzamides as β-secretase inhibitors for the treatment of Alzheimer ' s disease. PCT Int Appl WO2004094384 .
55. John, V., Maillard, M., Tucker, J., Aquino, J., Hom, R., Tung, J., Dressen, D., Shah, N., and Neitz, R.J. 2005 . Preparation of substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl protease and β-secretase inhibitors for treating conditions associated with amyloidosis such as Alzheimer ' s disease. PCT Int Appl WO2005087215 .
56. Schostarez, H.J. and Chrusciel, R.A. 2002 . Preparation of peptide-related hydrazine derivatives for treating Alzheimer ' s disease. PCT Int Appl WO2002100410 .
57. Schostarez, H.J., Chrusciel, R.A., and Centko, R.S. 2002 . Acylaminopropylhydrazines as β-secretase inhibitors. PCT Int Appl WO2002094768 .
58. Fang, L.Y. and John, V. 2002 . Compounds to treat Alzheimer ' s disease. PCT Int Appl WO2002002506 .
59. Romero, A.G., Schostarez, H.J., and Roels, C.M. 2003 . Preparation of amine 1,2-and 1,3-diol aldols and their use for treatment of Alzheimer ' s disease. PCT Int Appl WO2003043975.
60. Schostarez, H.J. and Hanson, G.J. 2003 . Aminodiols useful in the treatment of Alzheimer ' s disease and similar diseases. PCT Int Appl WO2003043618.
61. Schostarez, H.J. and Chrusciel, R.A. 2003 . Preparation of amine diols as β-secretase inhibitors for the treatment of Alzheimer ' s disease. PCT Int Appl WO2003006453.
62. Schostarez, H.J. and Chrusciel, R.A. 2003 . Preparation of diamine diols as β-secretase inhibitors for the treatment of Alzheimer ' s disease. PCT Int Appl WO2003006013.
63. Schostarez, H.J. and Chrusciel, R.A. 2002 . Preparation of aminediols as β-secretase inhibitors for the treatment of Alzheimer ' s and other diseases characterized by deposition of A β peptide. PCT Int Appl WO2002100818 .
64. Hom, R. and Varghese, J. 2004 . Preparation of hydroxyaminopropylbenzamides for the treatment of Alzheimer ' s disease. PCT Int Appl WO2004029019 .
65. Beck, J.P., Drowns, M., and Warpehoski, M.A. 2004 . Preparation of ring-containing aminoether carboxamides as β-secretase inhibitors for treating Alzheimer ' s disease and other diseases characterized by deposition of A β-peptide. PCT Int Appl WO2004024675 .
66. Jagodzinska, B. and Warpehoski, M.A. 2003 . Preparation of substituted amino carboxamides for the treatment of Alzheimer ' s disease. PCT Int Appl WO2003057721 .
67. Fisher, J.F., Jacobs, J.S., and Scherer, B.A. 2003 . Preparation of arylhydroxypropylamines used for treatment of Alzheimer ' s disease and to reduce amyloid beta peptide formation. PCT Int Appl WO2003029169 .
68. Tucker, J.A., Sherer, B.A., Xu, Y.Z., Brogley, L., Pulley, S.R., Jacobs, J.S., Beck, J.P., and John, V. 2004 . Preparation of hydroxypropyl benzamides as β-secretase inhibitors for the treatment of Alzheimer ' s disease. US Pat Appl Publ US2004039034.
69. Gailunas, A., Tucker, J.A., and John, V. 2003 . Preparation of phenethylamines for the treatment of Alzheimer ' s disease. PCT Int Appl WO2003027068 .
70. Tucker, J.A. 2005 . Preparation of hydroxypropyl amide peptide analogs for the treatment of Alzheimer ' s disease. PCT Int Appl WO2005042472 .
71. Ghosh, A.K., Shin, D., Downs, D., Koelsch, G., Lin, X., Ermolieff, J., and Tang, J. 2000 . Design of potent inhibitors for human brain memapsin 2 ( β-secretase) . J Am Chem Soc 122 : 3522-3523.
72. Tang, J.J.N., Hong, L., and Ghosh, A.K. 2001 . Inhibitors of memapsin 2 and use thereof. PCT Int Appl WO2001000665 .
73. Hong, L., Koelsch, G., Lin, X., Wu, S., Terzyan, S., Ghosh, A.K., Zhang, X.C., and Tang, J. 2000 . Structure of the protease domain of memapsin 2 ( β-secretase) complexed with inhibitor . Science 290 : 150-153 .
74. Tang, J.J.N., Lin, X., and Koelsch, G. 2001 . Catalytically active recombinant memapsin 2, 3D crystal structure-based inhibitor design, synthesis, and screening, for Alzheimer ' s disease treatment. PCT Int Appl WO2001000663 .
75. Hong, L., Turner, R.T. III, Koelsch, G., Shin, D., Ghosh, A.K., and Tang, J. 2002 . Crystal structure of memapsin 2 ( β-secretase) in complex with an inhibitor OM00-3 . Biochemistry 41 : 10963-10967.
76. Hong, L. and Tang, J. 2004 . Flap position of free memapsin 2 ( β-secretase), a model for flap opening in aspartic protease catalysis . Biochemistry 43 : 4689-4695 .
77. Ghosh, A.K., Kumaragurubaran, N., Hong, L., Lei, H., Hussain, K.A., Liu, C.-F., Devasamudram, T., Weerasena, V., Turner, R., Koelsch, G., Bilcer, G., and Tang, J. 2006 . Design, synthesis and X-ray structure of protein-ligand complexes: important insight into selectivity of memapsin 2 ( β-secretase) inhibitors . J Am Chem Soc 128 : 5310-5311 .
78. Ghosh, A., Lei, H., Devasamudram, T., Lui, C., Tang, J., and Bilcer, G. 2006 . Preparation of pseudopeptides which inhibit β-secretase activity. PCT Int Appl WO2006034296 .
79. Ghosh, A., Lei, H., Devasamudram, T., Liu, C., Tang, J., and Bilcer, G. 2006 . Preparation of pseudopeptides which inhibit β-secretase activity. PCT Int Appl WO2006034277 .
80. Ghosh, A.K., Tang, J., Bilcer, G., Chang, W., Hong, L., Koelsch, G.E., Loy, J.A., Turner, R.T., and Devasumadram, T. 2004 . Compounds which inhibit beta-secretase activity and methods of use thereof. U.S. Pat Appl Publ US2004121947.
81. Ghosh, A.K., Tang, J., Bilcer, G., Chang, W., Hong, L., Koelsch, G., Loy, J., and Turner, R.T. III . 2003 . Design of β-secretase inhibitors for treatment of Alzheimer ' s disease based on crystal structures of β-secretase and side chain interactions in inhibitor complexes. PCT Int Appl WO2003039454.
82. Tang, J., Koelsch, G., and Ghosh, A.K. 2002 . Inhibitors of memapsin 2 and their use in Alzheimer ' s disease treatment. PCT Int Appl WO2002053594.
83. Ghosh, A.K., Devasamudram, T., Hong, L., DeZutter, C., Xu, X., Weerasena, V., Koelsch, G., Bilcer, G., and Tang, J. 2005 . J Bioorg Med Chem Lett 15 : 15-20 .
84. Turner, R.T. III, Koelsch, G., Hong, L., Castenheira, P., Ghosh, A., and Tang, J. 2001. Subsite specificity of memapsin 2 ( β-secretase): implications for inhibitor design. [Erratum for 40 ( 34 ): 10001-10006 ]. Biochemistry 40 : 12230 .
85. Turner, R.T. III, Koelsch, G., Hong, L., Castenheira, P., Ghosh, A., and Tang, J. 2001 . Subsite specificity of memapsin 2 ( β-secretase): implications for inhibitor design . Biochemistry 40 : 10001-10006 .
86. Ghosh, A.K., Bilcer, G., Harwood, C., Kawahama, R., Shin, D., Hussain, K.A., Hong, L., Loy, J.A., Nguyen, C., Koelsch, G., Ermolieff, J., and Tang, J. 2001 . Structure-based design: potent inhibitors of human brain memapsin 2 ( β-secretase) . J Med Chem 44 : 2865-2868 .
87. Ghosh, A.K., Kumarahurubaran, N., Hong, L., Kulkarni, S.S., Xu, X., Chang, W., Weerasena, V., Turner, R., Koelsch, G., Bilcer, G., and Tang, J. 2007 . Design, synthesis, and X-ray structure of potent memapsin 2 ( β-secretase) inhibitors with isophthalamide derivatives as the PP-ligands . J Med Chem 50 : 2399-2407 .
88. Ghosh, A.K., Kumaragurubaran, N., Hong, L., Kulkarni, S., Xu, X., Miller, H.B., Reddy, D.S., Weerasena, V., Turner, R., Chang, W., Koelsch, G., and Tang, J. 2008 . Potent memapsin 2 ( β-secretase) inhibitors: design, synthesis, protein-ligand X-ray structure, and in vivo evaluation . Bioorg Med Chem Lett 18 : 1031-1036 .
89. Ghosh, A.K., Liu, C., Devasamudram, T., Lei, H., Swanson, L.M., Ankala, S.V., Lilly, J.C., and Bilcer, G.M. 2009 . Preparation of (3-hydroxy-4-amino-butan-2-yl)-3-[2-(thiazol-2-yl)pyrrolidine-1-carbonyl]benzamide derivatives and related compounds as selective beta-secretase inhibitors. PCT Int Appl WO2009042694 .
90. Ghosh, A.K., Liu, C., Devasamudram, T., Lei, H., Swanson, L.M., Ankala, V.S., Lilly, J.C., and Bilcer, G.M. 2009 . Isophthalamide compounds which inhibit beta-secretase activity and their preparation, pharmaceutical compositions and use in the treatment of Alzheimer ' s disease. PCT Int Appl WO2009015369 .
91. Ghosh, A.K., Kumaragurubaran, N., Liu, C., Devasamudram, T., Lei, H., Swanson, L., Ankala, S., Tang, J., and Bilcer, G. 2006 . Preparation of benzene-1,3-dicarboxamides which inhibit β-secretase activity. PCT Int Appl WO2006110668 .
92. See www.comentis.com .
93. Hu, J., Cwi, C.L., Smiley, D.L., Timm, D., Erickson, J.A., McGee, J.E., Yang, H.-C., Mendel, D., May, P.C., Shapiro, M., and McCarthy, J.R. 2003 . Design and synthesis of statine-containing BACE inhibitors . Bioorg Med Chem Lett 13 : 4335-4339 .
94. Lamar, J., Hu, J., Bueno, A.B., Yang, H.-C., Guo, D., Copp, J.D., McGee, J., Gitter, B., Timm, D., May, P., McCarthy, J., and Chen, S.-H. 2004 . PPhe *-ala-basedtapeptide mimetics are BACE inhibitors: P2 and P3 SAR . Bioorg Med Chem Lett 14 : 239-243 .
95. Chen, S.-H., Lamar, J., Guo, D., Kohn, T., Yang, H.-C., McGee, J., Timm, D., Erickson, J., Yip, Y., May, P., and McCarthy, J. 2004 . P3 cap modified Phe *-ala series BACE inhibitors . Bioorg Med Chem Lett 14 : 245-250 .
96. Rojo, I., Martin, J.A., Broughton, H., Timm, D., Erickson, J., Yang, H.-C., and McCarthy, J.R. 2006 . Macrocyclic peptidomimetic inhibitors of β-secretase (BACE): first X-ray structure of a macrocyclic peptidomimetic-BACE complex . B ioorg Med Chem Lett 16 : 191-195 .
97. Dally, R.D., Shepherd, T.A., Bender, D.M., and Rojo Garcia, M.I. 2005 . BACE inhibitors. PCT Int Appl WO2005108358 .
98. Durham, T.B., Hahn, P.J., Kohn, T.J., McCarthy, J.R., Broughton, H.B., Dally, R.D., Gonzalez-Garcia, M.R., Henry, K.J. Jr., Shepherd, T.A., Erickson, J.A., and Bueno-Melendo, A.B. 2006 . BACE inhibitors. PCT Int Appl WO2006034093 .
99. Brady, S.F., Singh, S., Crouthamel, M.-C., Holloway, M.K., Coburn, C.A., Garsky, V.M., Bogusky, M., Pennington, M.W., Vacca, J.P., Hazuda, D., and Lai, M.-T. 2004 . Rational design and synthesis of selective BACE-1 inhibitors . Bioorg Med Chem Lett 14 : 601-604 .
100. Coburn, C.A., Stachel, S.J., Li, Y.-M., Rush, D.M., Steele, T.G., Chen-Dodson, E., Holloway, M.K., Xu, M., Huang, Q., Lai, M.-T., DiMuzio, J., Crouthamel, M.-C., Shi, X.-P., Sardana, V., Chen, Z., Munshi, S., Kuo, L., Makara, G.M., Annis, D.A., Tadikonda, P.K., Nash, H.M., Vacca, J.P., and Wang, T. 2004 . Identification of a small molecule nonpeptide active site β-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases . J Med Chem 47 : 6117-6119 .
101. Stachel, S.J., Coburn, C.A., Steele, T.G., Jones, K.G., Loutzenhiser, E.F., Gregro, A.R., Rajapakse, H.A., Lai, M.-T., Crouthamel, M.-C., Xu, M., Tugusheva, K., Lineberger, J.E., Pietrak, B.L., Espeseth, A.S., Shi, X.-P., Chen-Dodson, E., Holloway, M.K., Munshi, S., Simon, A.J., Kuo, L., and Vacca, J.P. 2004 . Structure-based design of potent and selective cell-permeable inhibitors of human β-secretase (BACE-1) . J Med Chem 47 : 6447-6450 .
102. Coburn, C.A., Stachel, S.J., Jones, K.G., Steele, T.G., Rush, D.M., DiMuzio, J., Pietrak, B.L., Lai, M.-T., Huang, Q., Lineberger, J., Jin, L., Munshi, S., Holloway, M.K., Espeseth, A., Simon, A., Hazuda, D., Graham, S.L., and Vacca, J.P. 2006 . BACE-1 inhibition by a series of ψ[CH 2 NH] reduced amide isosteres . Bioorg Med Chem Lett 16 : 3635-3638 .
103. Stachel, S.J., Coburn, C.A., Sankaranarayanan, S., Price, E.A., Pietrak, B.L., Huang, Q., Lineberger, J., Espeseth, A., Jin, L., Ellis, J., Holloway, M.K., Munshi, S., Allison, T., Hazuda, D., Simon, A.J., Graham, S.L., and Vacca, J.P. 2006 . Macrocyclic inhibitors of β-secretase: functional activity in an animal model . J Med Chem 49 : 6147-6150 .
104. Yang, W., Lu, W., Lu, Y., Zhong, M., Sun, J., Thomas, A., Wilkinson, J.M., Fucini, R.V., Lam, M., Randal, M., Shi, X.-P., Jacobs, J.W., McDowell, R.S., Gordon, E.M., and Ballinger, M.D. 2006 . Aminoethylenes: a tetrahedral intermediate isostere yielding potent inhibitors of the aspartyl protease BACE-1 . J Med Chem 49 : 839-842.
105. Stanton, M.G., Stauffer, S.R., Gregro, A.R., Steinbeiser, M., Nantermet, P., Sankaranarayanan, S., Price, E.P., Wu, G., Crouthamel, M.-C., Ellis, J., Lai, M.-T., Espeseth, A.S., Shi, X.-P., Jin, L., Colussi, D., Pietrak, B., Huang, Q., Xu, M., Simon, A.J., Graham, S.L., Vacca, J.P., and Selnick, H. 2007 . Discovery of isonicotinamide derived β-secretase inhibitors: in vivo reduction of β-amyloid . J Med Chem 50 : 3431-3433 .
106. Nantermet, P.G., Rajapakse, H.A., Stanton, M.G., Stauffer, S.R., Barrow, J.C., Gregro, A.R., Moore, K.P., Steinbeiser, M.A., Swestock, J., Selnick, H.G., Graham, S.L., McGaughey, G.B., Colussi, D., Lai, M.-T., Sankaranarayanan, S., Simon, A.J., Munshi, S., Cook, J.J., Holahan, M.A., Michener, M.S., and Vacca, J.P. 2009 . Evolution of tertiary carbinamine BACE-1 inhibitors: Ab reduction in Rhesus CSF upon oral dosing . ChemMedChem 4 : 37-40.
107. Sankaranarayanan, S., Holahan, M.A., Colussi, D., Crouthamel, M.-C., Devanarayan, V., Ellis, J., Espeseth, A., Gates, A.T., Gram, S.L., Gregro, A.R., Hazuda, D., Hochman, J.H., Holloway, K., Jin, L., Kahana, J., Lai, M.-T., Lineberger, J., McGaughey, G., Moore, K.P., Nantermet, P., Pietrak, B., Price, E.A., Rajapakse, H., Stauffer, S., Steinbeiser, M.A., Seabrook, G., Selnick, H.G., Shi, X.-P., Stanton, M.G., Swestock, J., Tugusheve, K., Tyler, K.X., Vacca, J.P., Wong, J., Wu, G., Xu, M., Cook, J.J., and Simon, A.J. 2009 . First demonstration of cerebrospinal fluid and plasma A β lowering with oral administration of a β-site amyloid precursor protein-cleaving enzyme 1 inhibitor in nonhuman primates . J Pharm Exper Ther 328 : 131-140 .
108. Barrow, J.C., Stauffer, S.R., Rittle, K.E., Ngo, P.L., Yang, Z.Q., Selnick, H.G., Graham, S.L., Munshi, S., McGaughey, G.B., Holloway, M.K., Simon, A.J., Price, E.A., Sankaranarayanan, S., Colussi, D., Tugusheva, K., Lai, M.-T., Espeseth, A.S., Xu, M., Huang, Q., Wolfe, A., Pietrack, B., Zuck, P., Levorse, D.A., Hazuda, D., and Vacca, J.P. 2008 . Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of β-secretase . J Med Chem 51 : 6259-6262 .
109. Stauffer, S.R. and Graham, S.L. 2008 . Bicyclic spiropiperidine β-secretase inhibitors for the treatment of Alzheimer ' s disease. PCT Int Appl WO2008085509.
110. Stauffer, S.R., Hills, I.D., and Nomland, A. 2008 . Spiropiperidine β-secretase inhibitors for the treatment of Alzheimer ' s disease. PCT Int Appl WO2008054698.
111. Nantermet, P.G., Holloway, M.K., Moore, K.P., and Stauffer, S.R. 2008 . Preparation of macrocyclic spiropiperidine as β-secretase inhibitors. PCT Int Appl WO2008045250.
112. Egbertson, M.S., Stauffer, S.R., Coburn, C.A., Barrow, J.C., Yang, W., Lu, W., Fahr, B., Neilson, L.A., and Wai, J.M. 2008 . Preparation of aryldiazaspiro [4.5]decanone derivatives for use as anti-Alzheimer ' s agents. PCT Int Appl WO2008030412 .
113. Steele, T.G., Hills, I.D., Nomland, A.A., de León, P., Allison, T., McGaughey, G., Colussi, D., Tugusheva, K., Haugabook, S.J., Espeseth, A.S., Zuck, P., Graham, S.L., and Stachel, S.J. 2009 . Bioorg Chem Med Lett 19 : 17-20 .
114. Stachel, S.J., Coburn, C.A., Rush, D., Jones, K.L.G., Zhu, H., Rajapakse, H., Graham, S.L., Simon, A., Holloway, M.K., Allison, T.J., Munshi, S.K., Espeseth, A.S., Zuck, P., Colussi, D., Wolfe, A., Pietrak, B.L., Lai, M.-T., and Vacca, J.P. 2009 . Bioorg Med Chem Lett 19 : 2977-2980 .
115. Demont, E.H. Redshaw, S., and Walter, D.S. 2004 . Preparation of 3-(1,1-dioxotetrahydro-1,2-thiazin-2-yl) or 3-(1,1-dioxo-isothiazolidin-2-yl) substituted benzamide compounds for treatment of Alzheimer ' s disease. PCT Int Appl WO2004111022 .
116. Faller, A., MacPherson, D.T., Milner, P.H., Stanway, S.J., and Trouw, S.S. 2003 . Preparation of benzamide derivatives as inhibitors of Asp-2. PCT Int Appl WO2003045913 .
117. Faller, A., Milner, P.H., and Ward, J.G. 2003 . N-carbamoylalkylcarboxamides and-sulfonamides with Asp-2 inhibitory activity. PCT Int Appl WO2003045903 .
118. Clarke, B., Demont, E., Dingwall, C., Dunsdon, R., Faller, A., Hawkins, J., Hussain, I., MacPherson, D., Maile, G., Matico, R., Milner, P., Mosley, J., Naylor, A., O'Brien, A., Redshaw, S., Riddell, D., Rowland, P., Soleil, V., Smith, K.J., Stanway, S., Stemp, G., Sweitzer, S., Theobald, P., Vesey, D., Walter, D.S., Ward, J., and Wayne, G. 2008 . Bioorg Med Chem Lett 18 : 1011-1016 .
119. Clarke, B., Demont, E., Dingwall, C., Dunsdon, R., Faller, A., Hawkins, J., Hussain, I., MacPherson, D., Maile, G., Matico, R., Milner, P., Mosley, J., Naylor, A., O'Brien, A., Redshaw, S., Riddell, D., Rowland, P., Soleil, V., Smith, K.J., Stanway, S., Stemp, G., Sweitzer, S., Theobald, P., Vesey, D., Walter, D.S., Ward, J., and Wayne, G. 2008 . Bioorg Med Chem Lett 18 : 1017-1021 .
120. Beswick, P., Charrier, N., Clarke, B., Demont, E., Dingwall, C., Dunsdon, R., Faller, A., Gleave, R., Hawkins, J., Hussain, I., Johnson, C.N., MacPherson, D., Maile, G., Matico, R., Milner, P., Mosley, J., Naylor, A., O'Brien, A., Redshaw, S., Riddell, D., Rowland, P., Skidmore, J., Soleil, V., Smith, K.J., Stanway, S., Stemp, G., Stuart, A., Sweitzer, S., Theobald, P., Vesey, D., Walter, D.S., Ward, J., and Wayne, G. 2008 . Bioorg Med Chem Lett 18 : 1022-1026 .
121. Hussain, I., Hawkins, J., Harrison, D., Hille, C., Wayne, G., Cutler, L., Buck, T., Walter, D., Demont, E., Howes, C., Naylor, A., Jeffrey, P., Gonzalez, M.I., Dingwall, C., Michel, A., Redshaw, S., and Davis, J.B. 2007 . J Neurochem 100 : 802-809 .
122. Charrier, N., Clarke, B., Cutler, L., Demont, E., Dingwall, C., Dunsdon, R., East, P., Hawkins, J., Howes, C., Hussain, I., Jeffrey, P., Maile, G., Matico, R., Mosley, J., Naylor, A., O'Brien, A., Redshaw, S., Rowland, P., Soleil, V., Smith, K.J., Sweitzer, S., Theobald, P., Vesey, D., Walter, D.S., and Wayne, G. 2008 . J Med Chem 51 : 3313-3317 .
123. Demont, E.H., Redshaw, S., and Walter, D.S. 2006 . Novel hydroxyethylamine and ketone compounds having Asp2 inhibitory activity. PCT Int Appl WO2006103088 .
124. Demont, E.H., Redshaw, S., and Walter, D.S. 2006 . Preparation of substituted hydroxyethylamine compounds for treating Alzheimer ' s disease. PCT Int Appl WO2006040151 .
125. Demont, E.H., Redshaw, S., and Walter, D.S. 2005 . Preparation of N,N'-substituted-1,3-diamino-2-oxopropane derivatives as Asp2 inhibitors for use against diseases characterized by elevated β-amyloid levels or β-amyloid deposits, particularly Alzheimer ' s disease. PCT Int Appl WO2005113525.
126. Redshaw, S., Demont, E.H., and Walter, D.S. 2005 . Preparation of tricyclic indole hydroxyethylamine derivatives and their use in the treatment of Alzheimer ' s disease. PCT Int Appl WO2005058915.
127. Demont, E.H., Redshaw, S., and Walter, D.S. 2004 . Preparation of hydroxydiaminopropyl tricyclic indolecarboxamides for treatment of β-amyloid related disease. PCT Int Appl WO2004094430.
128. Demont, E.H., Redshaw, S., and Walter, D.S. 2004 . Preparation of hydroxyethylamine derivatives for the treatment of Alzheimer ' s disease. PCT Int Appl WO2004080376.
129. Demont, E.H., Faller, A., MacPherson, D.T., Milner, P.H., Naylor, A., Redshaw, S., Stanway, S.J., Vesey, D.R., and Walter, D.S. 2004 . Preparation of hydroxyethylamine derivatives for the treatment of Alzheimer ' s disease. PCT Int Appl WO2004050619 .
130. Demont, E.H., Redshaw, S., and Walter, D.S. 2006 . Tricyclic indole derivatives for use in the treatment of Alzheimer ' s disease. PCT Int Appl WO2006040148.
131. Demont, E.H., Redshaw, S., and Walter, D.S. 2006 . Heterocyclic ketone compounds for treating Alzheimer ' s disease. PCT Int Appl WO2006040149 .
132. Iserloh, U., Wu, Y., Cumming, J.N., Pan, J., Wang, L.Y., Stamford, A.W., Kennedy, M.E., Kuvelkar, R., Chen, X., Parker, E.M., Strickland, C., and Voigt, J. 2008 . Potent pyrrolidine-and piperidine-based BACE-1 inhibitors . Bioorg Med Chem Lett 18 : 414-417 .
133. Iserloh, U., Pan, J., Stamford, A.W., Kennedy, M.E., Zhang, Q., Zhang, L., Parker, E.M., McHugh, N.A., Favreau, L., Strickland, C., and Voigt, J. 2008 . Discovery of an orally efficacious 4-phenoxypyrrolidine-based BACE-1 inhibitor . B ioorg Med Chem Lett 18 : 418-422 .
134. Cumming, J.N., Le, T.X., Babu, S., Carroll, C., Chen, X., Favreau, L., Gaspari, P., Guo, T., Hobbs, D.W., Huang, Y., Iserloh, U., Kennedy, M.E., Kuvelkar, R., Li, G., Lowrie, J., McHugh, N.A., Ozgur, L., Pan, J., Parker, E.M., Saionz, K., Stamford, A.W., Strickland, C., Tadesse, D., Voigt, J., Wang, L., Wu, Y., Zhang, L., and Zhang, Q. 2008 . Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors . Bioorg Med Chem Lett 18 : 3236-3241 .
135. Stamford, A.W., Huang, Y., Li, G., Strickland, C.O., and Voigt, J.H. 2006 . Preparation of macrocyclic β-secretase inhibitors. PCT Int Appl WO2006014944 .
136. Decicco, C.P., Tebben, A.J., Thompson, L.A., and Combs, A.P. 2004 . Preparation of novel a-amino-γ-lactams as β-secretase inhibitors. PCT Int Appl WO2004013098 .
137. Meredith, J.E. Jr., Thompson, L.A., Toyn, J.H., Marcin, L., Barten, D.M., Marcinkeviciene, J., Kopcho, L., Kim, Y., Lin, A., Guss, V., Burton, C., Iben, L., Polson, C., Cantone, J., Ford, M., Drexler, D., Fiedler, T., Lentz, K.A., Grace, J.E. Jr., Kolb, J., Corsa, J., Pierdomenico, M., Jones, K., Olson, R.E., Macor, J.E., and Albright, C.F. 2008 . P-glycoprotein efflux and other factors limit brain amyloid β reduction by β-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice . J Pharm Exper Ther 326 : 502-512 .
138. Thompson, L.A., Boy, K.M., Shi, J., and Macor, J.E. 2006 . Preparation of isophthalates as β-secretase inhibitors. PCT Int Appl WO2006099352 .
139. Wu, Y.J., Zhang, Y., Good, A.C., Burton, C.R., Toyn, J.H., Albright, C.F., Macor, J.E., and Thompson, L.A. 2009 . Synthesis and SAR of hydroxyethylamine based phenylcarboxyamides as inhibitors of BACE . Bioorg Med Chem Lett 19 : 2654-2660 .
140. Auberson, Y., Glatthar, R., Salter, R., Simic, O., and Tintelnot-Blomley, M. 2005 . Preparation of substituted spirocyclic lactams as inhibitors of proteinase BACE1. PCT Int Appl WO2005035535 .
141. Machauer, R., Veenstra, S., Rondeau, J.-M., Tintelnot-Blomley, M., Betschart, C., Paganetti, P., and Neumann, U. 2009 . Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors . [Erratum for 19 :1361-1365] Bioorg Med Chem Lett 19 : 2366.
142. Machauer, R., Veenstra, S., Rondeau, J.-M., Tintelnot-Blomley, M., Betschart, C., Paganetti, P., and Neumann, U. 2009 . Structure-based design and synthesis of macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors . Bioorg Med Chem Lett 19 : 1361-1365 .
143. Betschart, C. and Tintelnot-Blomley, M. 2005 . Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof. PCT Int Appl WO2005003106 .
144. Auberson, Y., Betschart, C., Flohr, S., Glatthar, R., Simic, O., Tintelnot-Blomley, M., Troxler, T.J., Vangrevelinghe, E., and Veenstra, S.J. 2005 . A preparation of dibenz[b,f]oxepincarboxamide derivatives, useful for the treatment of neurological and vascular disorders related to β-amyloid generation and aggregation. PCT Int Appl WO2005014517 .
145. Machauer, R., Laumen, K., Veenstra, S., Rondeau, J.-M., Tintelnot-Blomley, M., Betschart, C., Jaton, A.-L., Desrayaud, S., Staufenbiel, M., Rabe, S., Paganetti, P., and Neumann, U. 2009 . Macrocyclic peptidomimetic β-secretase (BACE-1) inhibitors with activity in vivo . Bioorg Med Chem Lett 19 : 1366-1370 .
146. Abramowski, D., Wiederhold, K.-H., Furrer, U., Jaton, A.-L., Neuenschwander, A., Runser, M.J., Danner, S., Reichwald, J., Ammaturo, D., Staab, D., Stoeckli, M., Rueeger, H., Neumann, U., and Staufenbiel, M.D. 2008 . Dynamics of A β turnover and deposition in different β-amyloid precursor protein transgenic mouse models following ? .-secretase inhibition . J Pharmacol Exp Ther 327 : 411-424 .
147. Laumen, K., Machauer, R., Tintelnot-Blomley, M., and Veenstra, S.J. 2008 . Preparation of macrocyclic compounds useful as BACE inhibitors. PCT Int Appl WO2008009750 .
148. Machauer, R. 2008 . Preparation of macrocyclic compounds useful as BACE inhibitors. PCT Int Appl WO2008009734 .
149. Betschart, C., Koller, M., Laumen, K., Lerchner, A., Machauer, R., McCarthy, C., Tintelnot-Blomley, M., and Veenstra, S.J. 2007 . Preparation of macrocyclic lactam compounds useful as β-site APP-cleaving enzyme (BACE) inhibitors. PCT Int Appl WO2007077004.
150. Betschart, C., Lerchner, A., Machauer, R., Rueeger, H., Tintelnot-Blomley, M., and Veenstra, S.J. 2006 . Preparation of macrocyclic lactones for treatment of β-amyloid related disease. PCT Int Appl WO2006074950.
151. Lerchner, A., Machauer, R., Simic, O., and Tintelnot-Blomley, M. 2006 . Preparation of macrocyclic compounds as BACE inhibitors for treating vascular and neurological disorders related to β-amyloid generation. PCT Int Appl WO2006074940.
152. Auberson, Y., Betschart, C., Glatthar, R., Laumen, K., Machauer, R., Tintelnot-Blomley, M., Troxler, T.J., and Veenstra, S.J. 2005 . Preparation of macrocyclic lactams for treatment of neurological or vascular disorders related to β-amyloid generation and/or aggregation. PCT Int Appl WO2005049585 .
153. Hanessian, S., Maji, D.K., Shao, Z., Subramaniyan, G., Tintelnot-Blomley, M., Yang, G., and Yun, H. 2009 . Preparation of substituted cyclohexanecarboxamides useful as β-site APP-cleaving enzyme (BASE) inhibitors. PCT Int Appl WO2009013293 .
154. Frederiksen, M., Lueoend, R.M., McCarthy, C., Moebitz, H., Rondeau, J.-M., Roy, B.L., and Rueeger, H. 2008 . Preparation of 2-hydroxy-1,3-diaminopropane derivatives for the treatment of neurological or vascular disorders. PCT Int Appl WO2008062044 .
155. Briard, E., Lueoend, R.M., Machauer, R., Moebitz, H., Rogel, O., Rondeau, J.-M., Rueeger, H., Tintelnot-Blomley, M., and Veenstra, S.J. 2009 . Preparation of aminobenzyl substituted cyclic sulfones as BACE inhibitors. PCT Int Appl WO2009024615.
156. Rueeger, H., Mccarthy, C., Moebitz, H., Rondeau, J.-M., and Tintelnot-Blomley, M. 2007 . Preparation of cyclic sulfones useful as β-secretase (bace) inhibitors. PCT Int. Appl WO2007093621 .
157. Xue, Q., Albrecht, B.K., Andersen, D.L., Bartberger, M., Brown, J., Brown, R., Chaffee, S.C., Cheng, Y., Croghan, M., Graceffa, R., Harried, S., Hitchcock, S., Hungate, R., Judd, T., Kaller, M., Kreiman, C., La, D., Lopez, P., Masse, C.E., Monenschein, H., Nguyen, T., Nixey, T., Patel, V.F., Pennington, L., Weiss, M., Yang, B., and Zhong, W. 2007 . Preparation of 2-hydroxy-1,3-diaminoalkanes including spiro substituted chroman derivatives as β-secretase modulators and their use for treatment Alzheimer ' disease and related condition. PCT Int Appl WO2007061930 .
158. Albrecht, B.K., Andersen, D.L., Bartberger, M., Brown, J., Brown, R., Chaffee, S.C., Cheng, Y., Croghan, M., Graceffa, R., Harried, S., Hitchcock, S., Hungate, R., Judd, T., Kaller, M., Kreiman, C., La, D., Lopez, P., Masse, C.E., Monenschein, H., Nguyen, T., Nixey, T., Patel, V.F., Pennington, L., Weiss, M., Xue, Q., Yang, B., and Zhong, W. 2007 . Preparation of 2-hydroxy-1,3-diaminoalkanes including spiro substituted chroman derivatives as β-secretase modulators and their use for treatment Alzheimer ' s disease and related condition. PCT Int Appl WO2007062007 .
159. Zhong, W., Hitchcock, S., Albrecht, B.K., Bartberger, M., Brown, J., Brown, R., Chaffee, S.C., Cheng, Y., Croghan, M., Graceffa, R., Harried, S., Hickman, D., Horne, D., Hungate, R., Judd, T., Kaller, M., Kreiman, C., La, D., Lopez, P., Masse, C.E., Monenschein, H., Nguyen, T., Nixey, T., Patel, V.F., Pennington, L., Weiss, M., Xue, Q., and Yang, B. 2007 . Preparation of 2-hydroxy-1,3-diaminoalkanes including spiro substituted chroman derivatives as β-secretase modulators and their use for treatment Alzheimer ' s disease and related condition. PCT Int Appl WO2007061670 .
160. Zhong, W., Hitchcock, S., Patel, V.F., Croghan, M., Dineen, T., Horne, D., Kaller, M., Kreiman, C., Lopez, P., Monenschein, H., Nguyen, T., Pennington, L., Xue, Q., and Yang, B. 2008 . Substituted hydroxyethyl amine compounds as beta-secretase modulators and their preparation and use in the treatment of Alzheimer ' s disease and related conditions. PCT Int Appl WO2008147544 .
161. Zhong, W., Hitchcock, S., Patel, V.F., Croghan, M., Dineen, T., Harried, S., Horne, D., Judd, T., Kaller, M., Kreiman, C., Lopez, P., Monenschein, H., Nguyen, T., Weiss, M., Xue, Q., and Yang, B. 2008 . Substituted hydroxyethyl amine compounds as beta-secretase modulators and their preparation and use in the treatment of Alzheimer ' s disease and related conditions. PCT Int Appl WO2008147547 .
162. Graceffa, R., Kaller, M., La, D., Lopez, P., Patel, V.F., and Zhong, W. 2009 . Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use. PCT Int Appl WO2009064418 .
163. Hamada, Y., Igawa, N., Ikari, H., Ziora, Z., Nguyen, J.-T., Yamani, A., Hidaka, K., Kimura, T., Saito, K., Hayashi, Y., Ebina, M., Ishiura, S., and Kiso, Y. 2006 . Bioorg Med Chem Lett 16 : 4354-4359 ; and references therein.
164. Asai, M., Hattori, C., Iwata, N., Saido, T.C., Sasagawa, N., Szab ó, B., Hashimoto, Y., Maruyama, K., Tanuma, S., Kiso, Y., and Ishiura, S. 2006 . J Neurochem 96 : 533-540 .
165. Hamada, Y., Abdel-Rahman, H., Yamani, A., Nguyen, J.-N., Stochaj, M., Hidaka, K., Kimura, T., Hayashi, Y., Saito, K., Ishiura, S., and Kiso, Y. 2008 . Bioorg Med Chem Lett 18 : 1649-1653 .
166. Hamada, Y., Ohta, H., Miyamoto, N., Sarma, D., Hamada, T., Nakanishi, T., Yamasaki, M., Yamani, A., Ishiura, S., and Kiso, Y. 2009 . Bioorg Med Chem Lett 19 : 2435-2439 .
167. Cole, D.C., Manas, E.S., Stock, J.R., Condon, J.S., Jennings, L.D., Aulabaugh, A., Chopra, R., Cowling, R., Ellingboe, J.W., Fan, K.Y., Harrison, B.L., Hu, Y., Jacobsen, S., Jin, G., Lin, L., Lovering, F.E., Malamas, M.S., Stahl, M.L., Strand, J., Sukhdeo, M.N., Svenson, K., Turner, M.J., Wagner, E., Wu, J., Zhou, P., and Bard, J. 2006 . Acylguanidines as small molecule β-secretase inhibitors . J Med Chem 49 : 6158-6161 .
168. Jennings, L.D., Cole, D.C., Stock, J.R., Sukhdeo, M.N., Ellingboe, J.W., Cowling, R., Jin, G., Manas, E.S., Fan, K.Y., Malamas, M.S., Harrison, B.L., Jacobsen, S., Chopra, R., Lohse, P.A., Moore, W.J., O'Donnell, M.-M., Hu, Y., Robichaud, A.J., Turner, M.J., Wagner, E., and Bard, J. 2008 . Acylguanidine inhibitors of β-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocket. Bioorg Med Chem Lett 18 : 767-771.
169. Cole, D.C., Stock, J.R., Chopra, R., Cowling, R., Ellingboe, J.W., Fan, K.Y., Harrison, B.L., Hu, Y., Jacobsen, S., Jennings, L.D., Jin, G., Lohse, P.A., Malamas, M.S., Manas, E.S., Moore, W.J., O'Donnell, M.-M., Olland, A.M., Robichaud, A.J., Svenson, K., Wu, J., Wagner, E., and Bard, J. 2008 . Acylguanidine inhibitors of β-secretase: optimization of the pyrrole ring substituents extending into the S 1 and S 3 substrate binding pockets . Bioorg Med Chem Lett 18 : 1063-1066 .
170. Fobare, W.F., Solvibile, W.R., Robichaud, A.J., Malamas, M.S., Manas, E., Turner, J., Hu, Y., Wagner, E., Chopra, R., Cowling, R., Jin, G., and Bard, J. 2008 . Thiophene substituted acylguanidines as BACE1 inhibitors . Bioorg Med Chem Lett 17 ; 5353-5356 .
171. Malamas, M.S., Fobare, W.F., Solvibile, W.R., Lovering, F.E., Condon, J.S., and Robichaud, A.J. 2006 . Amino-pyridines as inhibitors of β-secretase and their preparation, and pharmaceutical compositions. US Pat Appl Publ US2006173049 .
172. Nowak, P., Aulabaugh, A., Chen, J., Cole, D.C., Chopra, R., Cowling, R., Dar, M., Ellingboe, J.W., Fan, K.Y., Hu, B., Jacobsen, S., Jani, M., Jin, G., Lo, M.-C., Malamas, M.S., Manas, E.S., Narasimhan, R., Robichaud, A., Sabus, C., Stock, J.R., Tischler, M., Turner, J., Wagner, E., Zhou, P., and Bard, J. 2007 . Hit-to-lead optimization of aminohydantoins as β-secretase inhibitors . 233rd ACS National Meeting, Chicago, IL, United States, March 25-29, MEDI-307.
173. Malamas, M.S., Erdei, J., Gunawan, I., Pawel, N., Chlenov, M., Robichaud, A.J., Turner, J., Hu, Y., Wagner, E., Aschmies, S., Comery, T., Di, L., Fan, K., Chopra, R., Oganesian, A., Huselton, C., and Bard, J. 2007 . Aminohydantoins as highly potent, selective and orally active BACE1 inhibitors . 233rd ACS National Meeting, Chicago, IL, March 25-29, MEDI-234 .
174. Yan, Y., Zhou, P., Malamas, M., Aschmies, S., Bard, J., Comery, T., Hu, Y., Oganesian, A., Turner, J., Wagner, E., Reinhart, P., and Robichaud, A. 2008 . Syntheses and biological properties of carbocyclic substituted aminohydantoin derivatives . 235th ACS National Meeting, New Orleans, LA, April 6-10, MEDI-258 .
175. Zhou, P., Yan, Y., Fobare, W.F., Malamas, M., Solvibile, W.R., Chopra, R., Fan, K.Y., Hu, Y., Turner, J., Wagner, E., Magolda, R.L., Abougharbia, M.A., Reinhart, P., Pangalos, M., Bard, J., and Robichaud, A. 2008 . Substituted-pyrrole 2-amino-3,5-dihyro-4H-imidazol-4-ones as highly potent BACE1 inhibitors: optimization of the S3 pocket . 235th ACS National Meeting, New Orleans, LA, April 6-10, MEDI-259 .
176. Solvibile, W.R., Fobare, W.F., Abou-Gharbia, M., Andrae, P.M., Aschmies, S., Chopra, R., Fan, K.Y., Hu, Y., Magolda, R.L., Pangalos, M., Quagliato, D.A., Turner, J., Wagner, E., Yan, Y., Zhou, P., Bard, J., Malamas, M., and Robichaud, A. 2008 . 2-Substituted-pyrrole 2-amino-3,5-dihydro-4H-imidazol-4-ones: highly potent, and selective BACE1 inhibitors . 235th ACS National Meeting, New Orleans, LA, April 6-10, MEDI-256 .
177. Erdei, J., Gunawan, I., Quagliato, D.A., Yan, Y., Fobare, W.F., Solvibile, W.R., Fan, K., Robichaud, A., Turner, J., Wagner, E., Hu, Y., Aschmies, S., Chopra, R., Bard, J., and Malamas, M. 2008 . N-Alkyl substituted-pyrrole 2-amino-3,5-dihydro-4H-imidazol-4-ones as potent, and selective BACE1 inhibitors . 235th ACS National Meeting, New Orleans, LA, April 6-10, MEDI-255.
178. Fobare, W.F., Malamas, M., Robichaud, A., Solvibile, W.R., Zhou, P., Quagliato, D.A., Erdei, J., Gunawan, I., Yan, Y., Andrae, P.M., Turner, J., Wagner, E., Hu, Y., Fan, K.Y., Aschmies, S., Chopra, R., and Bard, J. 2008 . Substituted-pyrrole 2-amino-3,5-dihydro-4H-imidazol-4-ones as highly potent and selective BACE1 inhibitors . 235th ACS National Meeting, New Orleans, LA, April 6-10, MEDI-182 .
179. Yan, Y., Zhou, P., Malamas, M.S., Li, Y., Aschmies, S., Bard, J., Bernotas, R.C., Chopra, R., Comery, T., Fan, K.Y., Hu, Y., Oganesian, A., Turner, J., Wagner, E., Wang, Z., Reinhart, P., and Robichaud, A.J. 2007 . Piperidinyl-2-aminohydantoin derivatives for the inhibition of beta-secretase . 233rd ACS National Meeting, Chicago, IL, March 25-29, MEDI-309 .
180. Malamas, M.S., Erdei, J., Gunawan, I., Barnes, K., Johnson, M., Robichaud, A., Turner, J., Hui, Y., Hu, Y., Chopra, R., Fan, K., and Bard, J. 2008 . Thienyl aminohydantoins as potent BACE1 inhibitors . 236th ACS National Meeting, Philadelphia, PA, August 17-21, MEDI-297 .
181. Yan, Y., Zhou, P., Malamas, M.S., Li, Y., Aschmies, S., Bard, J., Bernotas, R.C., Chopra, R., Comery, T., Fan, K.Y., Hu, Y., Oganesian, A., Turner, J., Wagner, E., Wang, Z., Reinhart, P., and Robichaud, A.J. 2007 . Piperidinyl-2-aminohydantoin derivatives for the inhibition of beta-secretase . 233rd ACS National Meeting, Chicago, IL, March 25-29, MEDI-309 .
182. Zhou, P., Bard, J., Chopra, R., Fan, K.Y., Hu, Y., Li, Y., Magolda, R.L., Malamas, M.S., Pangalos, M., Reinhart, P., Turner, J., Wang, Z., and Robichaud, A.J. 2007 . Pyridinylaminohydantoins as small molecule BACE1 inhibitors: Exploration of the S3 pocket . 234th ACS National Meeting, Boston, MA, August 19-23, MEDI-294 .
183. Malamas, M.S., Barnes, K., Hui, Y., Zhou, P., Robichaud, A.J., Bard, J., Turner, J., Hu, Y., Fan, K.Y., Chopra, R., and Johnson, M. 2007 . Substituted-pyridine 2-amino-3,5-dihydro-4H-imidazol-4-ones as highly potent, and selective BACE1 inhibitors . 234th ACS National Meeting, Boston, MA, August 19-23, MEDI-236 .
184. Malamas, M.S., Barnes, K., Hui, Y., Zhou, P., Robichaud, A.J., Bard, J., Turner, J., Hu, Y., Fan, K.Y., Chopra, R., and Johnson, M. 2007 . Substituted-pyridine 2-amino-3,5-dihydro-4H-imidazol-4-ones as highly potent, and selective BACE1 inhibitors . 234th ACS National Meeting, Boston, MA, August 19-23, MEDI-236 .
185. Quagliato, D.A., Andrae, P., Chlenov, M., Fan, K., Li, D., Robichaud, A., Turner, J., Wagner, E., Bard, J., and Malamas, M. 2008 . Rigid analogs of 4,4-diaryl-iminohydantoins as potent inhibitors of beta-secretase . 235th ACS National Meeting, New Orleans, LA, April 6-10, MEDI-257 .
186. Malamas, M.S., Robichaud, A.J., Porte, A.M., Morris, K.M., Solvibile, W.R., and Kim, J.-L. 2008 . Preparation of amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone derivatives as inhibitors of β-secretase. PCT Int Appl WO2008118379 .
187. Malamas, M.S., Robichaud, A.J., Porte, A.M., Solvibile, W.R., Morris, K.M., Antane, S.A., Kim, J.-L., and Mcdevitt, R.E. 2008 . Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as β-secretase inhibitors and their preparation, and use in the treatment of β-amyloid deposits and neurofibrillary tangles. PCT Int Appl WO2008115552.
188. Malamas, M.S., Barnes, K.D., and Johnson, M.R. 2008. Imidazole amines as inhibitors of beta-secretase and their preparation, pharmaceutical compositions and use in the treatment of diseases associated with elevated β-amyloid deposits and β-amyloid levels. PCT Int Appl WO2008022024.
189. Malamas, M.S., Erdei, J.J., Fobare, W.F., Quagliato, D.A., Antane, S.A., and Robichaud, A.J. 2007 . Preparation of imidazolone derivatives as inhibitors of β-secretase. US Pat Appl Publ. US2007072925.
190. Malamas, M.S., Gunawan, I.S., Erdei, J.J., Nowak, P.W., Stock, J.R., and Yan, Y. 2007 . Cycloalkyl amino-hydantoin compounds and use thereof for β-secretase modulation and treatment of diseases with β-amyloid deposits and neurofi- brillary tangles. US Pat Appl Publ. US2007027199.
191. Malamas, M.S., Zhou, P., Fobare, W.F., Solvibile, W.R., Gunawan, I.S., Erdei, J.J., Yan, Y., Andrae, P.M., and Quagliato, D.A. 2007 . Preparation of amino-5-(5-membered)hetero-arylimidazolone compounds as β-secretase modulators for treating diseases involving β-amyloid deposits and neurofibrillary tangles. US Pat Appl Publ. US2007004786.
192. Zhou, P., Malamas, M.S., Li, Y., Robichaud, A.J., and Quagliato, D.A. 2007 . Preparation of aminoheteroarylimidazolone compounds for use as β-secretase modulators to treat β-amyloid and neurofibrillary tangle associated diseases. US Pat Appl Publ. US2007004730.
193. Malamas, M.S., Erdei, J.J., Gunawan, I.S., Nowak, P., and Harrison, B.L. 2006 . Preparation of 8,8-diphenyl-2,3,4,8-tetrahydroimidazo[1,5-a]pyrimidin-6-amines as β-secretase inhibitors for the treatment of Alzheimer ' s disease and related disorders. PCT Int Appl WO2006076284.
194. Malamas, M.S., Erdei, J.J., Gunawan, I.S., Barnes, K.D., Johnson, M.R., and Hui, Y. 2005 . Preparation of diphenylimidazopyrimidine and-imidazole amines as selective inhibitors of β-secretase for use against Alzheimer ' s disease and other disorders. US Pat Appl Publ. US2005282826.
195. Malamas, M.S., Erdei, J.J., Gunawan, I.S., Zhou, P., Yan, Y., and Quagliato, D.A. 2005 . Preparation of amino-5,5-diphenylimidazolone derivatives for inhibition of beta-secretase and treatment of β-amyloid-related diseases. US Pat Appl Publ. US2005282825 .
196. Yan, Y., Zhou, P., Fan, Y., Robichaud, A.J., and Malamas, M.S. 2008 . Preparation of indolylalkyl pyridin-2-amines for the inhibition of β-secretase. PCT Int Appl WO2008036196 .